Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.30 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5610680 | 1.00 | TSHR (0.40) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL5610286 | 1.00 | TSHR (0.40) | TSHRLMNATHRBALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL809498 | 0.97 | TSHR (0.38) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL15454 | 0.93 | TSHR (0.46) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL1668311 | 0.91 | TSHR (0.33) | TSHRLMNATHRB | |
| Bromide SCHEMBL6048229 | 0.89 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL16180725 | 0.89 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL31529973 | 0.89 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL27835200 | 0.89 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL22638177 | 0.89 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9120836-B2 | Method for preparing transition metal complexes, transition metal complexes prepared using the method, catalyst composition containing the complexes | LG CHEM, LTD. (KR) | 2015-09-01 | — | — | US | disclosed |
| US-20110177935-A1 | METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES | LG CHEM, LTD. (KR) | 2011-07-21 | — | — | US | disclosed |
| US-7649063-B2 | Supported metal alkyl compound and its preparation | BASELL POLYOLEFINE GMBH (DE) | 2010-01-19 | — | — | US | disclosed |
| US-20080306224-A1 | Supported Metal Alkyl Compound And Its Preparation | BASELL POLYOLEFINE GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
| EP-1670586-A1 | SUPPORTED METAL ALKYL COMPOUND AND ITS PREPARATION | Basell Polyolefine GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005039763-A1 | SUPPORTED METAL ALKYL COMPOUND AND ITS PREPARATION | BASELL POLYOLEFINE GMBH (DE) | 2005-05-06 | — | — | WO | disclosed |
| EP-1003753-A1 | COMPOUNDS CONTAINING BORON AND ALUMINIUM | Basell Polyolefine GmbH (DE) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999006414-A1 | COMPOUNDS CONTAINING BORON AND ALUMINIUM | TARGOR GMBH (DE) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110177935-A1 | METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES | PPOX, C9, C5 | TSHR 3519/4885LMNA 2472/4885THRB 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.